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A recent study has suggested that fibroblasts can be
converted into mouse-induced neural stem cells
(miNSCs) through the expression of defined factors.
However, successful generation of human iNSCs
(hiNSCs) has proven challenging to achieve. Here,
using microRNA (miRNA) expression profile ana-
lyses, we showed that let-7 microRNA has critical
roles for the formation of PAX6/NESTIN-positive
colonies from human adult fibroblasts and the prolif-
eration and self-renewal of hiNSCs. HMGA2, a let-
7-targeting gene, enables induction of hiNSCs that
displayed morphological/molecular features and
in vitro/in vivo differentiation potential similar to
H9-derived NSCs. Interestingly, HMGA2 facilitated
the efficient conversion of senescent somatic cells
or blood CD34+ cells into hiNSCs through an interac-
tionwith SOX2, whereas other combinations or SOX2
alone showed a limited conversion ability. Taken
together, these findings suggest that HMGA2/let-7
facilitates direct reprogramming toward hiNSCs
in minimal conditions and maintains hiNSC self-
renewal, providing a strategy for the clinical treat-
ment of neurological diseases.
INTRODUCTION
Direct lineage conversion strategies have been developed for the
conversion of animal and human somatic cells into other lineage-
specific cells to overcome the issues of induced pluripotent stemCcells (iPSCs). However, these direct reprogramming technolo-
gies have limitations, as these lineage-specific cells are fully
differentiated with limited proliferation potential and are difficult
to use for transplantation or clinical trials. Recently, it has been
reported that neural stem cells can be successfully generated
through defined factors in mouse fibroblasts (Han et al., 2012;
Thier et al., 2012). Because directly converted neuronal cell pop-
ulations are heterogeneous and unable to proliferate, the deriva-
tion of neural stem cells (NSCs) is desired to obtain sufficient
amounts of cells with relatively safe and homogeneous cell pop-
ulations. More recently, Ring et al. (2012) reported that SOX2 is
sufficient to generate mouse induced NSCs (iNSCs) frommouse
embryonic fibroblasts. However, the direct conversion of human
adult somatic cells into human iNSCs (hiNSCs) has not been well
characterized yet.
High-mobility group A2 (HMGA2) is an architectural transcrip-
tion factor that potentiates the effects of transcription factors
through alterations of chromatin structures, reflecting binding
to the minor groove of AT-rich DNA sequences (Reeves, 2001).
Hmga2 overexpression elevates self-renewal activity in purified
hematopoietic stem cells (Copley et al., 2013) and rescues the
in vitro aging process of mesenchymal stem cells (MSCs) (Yu
et al., 2013). Hmga2 is highly expressed in fetal NSCs, but its
expression gradually declines with age. Hmga2 promotes the
self-renewal of NSCs through the repression of p16Ink4a and
p19Arf (Nishino et al., 2008). Furthermore, HMGA2 is essential
for the open chromatin state of neural precursor cells (NPCs)
at early developmental stages and facilitates the reprogramming
of late-stage NPCs into cells with early stage-specific capacities
(Kishi et al., 2012).
Lethal-7 (let-7) microRNAs (miRNAs) target HMGA2, which
contains seven target sites in its 30 UTR, and these miRNAs
show inverse expression patterns during fetal developmentell Reports 10, 441–452, January 20, 2015 ª2015 The Authors 441
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and adult aging (Fusco and Fedele, 2007). Recent studies have
shown that let-7 miRNAs are involved in the regulation of the
nervous system, including neural cell specification and self-
renewal regulation in NSCs (Rybak et al., 2008; Zhao et al.,
2010). However, the effects of HMGA2 and let-7 on the direct
reprogramming of human fibroblasts into hiNSCs remain
unknown. Here, we report that overexpressing HMGA2/anti-
let-7b in combination with SOX2 facilitated direct reprogram-
ming of human somatic cells toward hiNSCs.
RESULTS
Expression Profiling and Validation of miRNAs in hiNSCs
hiNSCs were generated from adult human dermal fibroblasts
(hDFs) using methods described previously with modifications
(Ring et al., 2012). Briefly, hDFs cultured with STO feeder cells
on poly-L-ornithine (PLO) and fibronectin (FN)-coated glass
coverslips were infected with retroviral SOX2. NSC-like col-
onies were generated from SOX2-transduced hDFs within 2
or 3 weeks of infection. These colonies were collected and
cultured as neurospheres for three or four passages. The
neurospheres were seeded and grown as a monolayer, and
the neurosphere culture procedures were repeated at least
three times to generate a homogenous population of hiNSCs.
SOX2-transduced hiNSCs expressed NSC-specific markers,
such as PAX6, NESTIN, VIMENTIN, and SOX2, and had a
morphology similar to H9-derived NSCs (H9-NSCs) (Figures
1A–1E and S2A).
We next determined the miRNA profiles of hDFs, H9-NSCs,
and SOX2-transduced hiNSCs through microarray analyses.
To examine whether SOX2-transduced hiNSCs exhibit a
neuronal identity, we selected brain-specific miRNAs from the
microarray data set. The brain-specific miRNA expression
pattern of SOX2-transduced hiNSCs was more similar to that
of H9-NSCs than hDFs (Figure 1F); however, a subset of miRNAs
expressing similar patterns in hiNSCs and hDFs was also de-
tected, likely reflecting residual epigenetic memory. Previously,
a role for let-7, miR-9, and miR-124 in the control of NSC main-
tenance and direct reprogramming process has been reported
(Kawahara et al., 2012; Yoo et al., 2011; Zhao et al., 2010). There-Figure 1. Role of let-7b in hDF-iNSC Derivation
(A and B) Morphology of human dermal fibroblasts (hDFs) (A) and iNSCs deriv
represents 100 mm.
(C) Bright-field image of early neurosphere-like colonies generated through SOX2
multiple passages for rounds of neurosphere generation, and grown in PLO/FN-
(D and E) Immunocytochemistry analysis of NSC-specific marker proteins in hDF
Nuclei were counterstained with DAPI. The scale bar represents 100 mm.
(F and G) Heatmap of brain-specific miRNAs (F) and reprogramming-related miR
(H) qRT-PCR analysis of let-7/miR-98 family expression in hDFs, H9-NSCs, and h
(I and J) qRT-PCR validation of miR-124-3p (I) and miR-9-5p/miR-9-3p (J) in hD
reactions. **p < 0.01.
(K) Relative expression levels of the ESC-specific miR-302/miR-367 family were m
Error bars denote the SD of triplicate reactions. **p < 0.01.
(L) The efficiency of PAX6- and NESTIN-positive colony formation was measure
let-7b into SOX2-transduced hDFs. Error bars denote the SD of seven separate
(M and N) Relative expression levels of MYC, LIN28, and HMGA2 were measu
miR-CTL-, and let-7b-transfected hDFs. Error bars denote the SD of triplicate re
See also Figure S1.
Cfore, we extracted reprogramming-related miRNAs from the
microarray data set and validated them via quantitative real-
time RT-PCR (qRT-PCR) (Figures 1G–1K). Interestingly, all let-
7/miR-98 family members were downregulated in H9-NSCs
and SOX2-transduced hiNSCs compared with hDFs (Figure 1H).
It has been reported that neural lineage-specific miRNAs, such
as miR-9-5p, miR-9-3p, and miR-124, play key roles in the con-
version of fibroblasts into functional neurons (Xue et al., 2013;
Yoo et al., 2011). The expression levels of miR-9-5p, miR-9-3p,
and miR-124 were upregulated in H9-NSCs and SOX2-
transduced hiNSCs compared with hDFs (Figures 1I and 1J).
However, significant alterations in the expression levels of the
embryonic-stem-cell-specific miR-302/miR-367 family were
not detected between hDFs, H9-NSCs, and hiNSCs, whereas
the abundant expression of these miRNAs was detected in
human embryonic stem cells (hESCs) (Figure 1K).
Let-7b Regulates iNSC Reprogramming Efficiency
and Self-Renewal
To determine whether miRNA activity promotes the reprogram-
ming of hDFs into hiNSCs, we transfected miR-124, miR-9-
5p, miR-9-3p, anti-let-7b, let-7b, or miR-CTL into SOX2-trans-
duced cells. The overexpression of miR-124, miR-9-5p, and
miR-9-3p did not enhance the production of PAX6/NESTIN-pos-
itive colonies. In the presence of these miRNAs, SOX2-trans-
duced hDFs were converted into neuron-like cells rather than
NSC-like colonies (data not shown). However, let-7b inhibition
increased reprogramming efficiency approximately 3.5-fold
over anti-miR-CTL, whereas let-7b overexpression significantly
decreased reprogramming efficiency (Figure 1L). To gain insight
into let-7 target genes, we analyzed let-7-relevant genes using
ingenuity pathway analysis (IPA) software (Figures S1A–S1C).
Among the top 15 IPA findings, we selected MYC, LIN28, and
HMGA2, which are known NSC-related genes. To further assess
the role of SOX2 and let-7 regulators on the expression of
MYC, LIN28, and HMGA2, we transduced SOX2 into hDFs and
investigated expression levels on days 3 and 7. We found that
the expression of MYC, LIN28, HMGA2, and let-7b was not
altered by the transduction of hDFs with SOX2 (Figures S1D
and S1E). Furthermore, transfection with let-7b or anti-let-7bed from SOX2-transduced hDFs; (B) bright-field microscopy. The scale bar
transduction. Neurosphere-like colonies were manually isolated, subjected to
coated culture dishes. The scale bar represents 100 mm.
-iNSCs using antibodies against PAX6, NESTIN (D), and VIMENTIN, SOX2 (E).
NAs (G) in hDFs, H9-NSCs, and hDF-iNSCs (SOX2).
DF-iNSCs (SOX2). Error bars denote the SD of triplicate reactions. **p < 0.01.
Fs, H9-NSCs, and hDF-iNSCs (SOX2). Error bars denote the SD of triplicate
easured through qRT-PCR in hDFs, H9-NSCs, hDF-iNSCs (SOX2), and hESCs.
d after the transfection of miR-124-3p, miR-9-5p, miR-9-3p, anti-let-7b, and
assays. *p < 0.05; **p < 0.01.
red by qRT-PCR (M) and western blotting (N) in anti-miR-CTL-, anti-let-7b-,
actions. **p < 0.01.
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significantly regulated the expression level of HMGA2, but not
MYC and LIN28, in hDFs, suggesting that HMGA2 expression
was increased during the SOX2/anti-let-7b-mediated hiNSC re-
programming process (Figures 1M and 1N).
We next transfected let-7b into hiNSCs and measured cell
proliferation through 5-bromodeoxyuridine (BrdU) labeling of
dividing cells to determine whether let-7b regulates hiNSC prolif-
eration. The transfection of let-7b decreased hiNSC proliferation
in a dose-dependent manner, confirmed by the reduced per-
centage of BrdU-positive cells (Figures S1F and S1G). To assess
whether let-7b regulates the self-renewal of hiNSCs, we per-
formed a neurosphere-forming assay. Let-7b-transfected
hiNSCs were smaller than miR-CTL-transfected hiNSCs and
generated significantly fewer secondary neurospheres upon
subcloning in response to increasing concentrations of let-7b
(Figures S1H–S1J). These results demonstrated roles for let-7b
in promoting reprogramming efficiency toward hiNSCs in com-
bination with SOX2 and in regulating hiNSC proliferation and
self-renewal.
The let-7b Target HMGA2 Promotes hiNSC
Reprogramming
Previous studies and our IPA data have shown that let-7 expres-
sion inversely correlates with expression of MYC, LIN28, and
HMGA2 (Mayr et al., 2007; Rybak et al., 2008; Sampson et al.,
2007). Here, we demonstrated that the overexpression of
MYC, LIN28, and HMGA2 in combination with SOX2 increased
cell proliferation compared with the overexpression of SOX2
alone. Among these factors, HMGA2 had the slightest effect
on proliferation (Figure 2A). We examined whether MYC,
LIN28, and HMGA2 in combination with SOX2 could promote
reprogramming toward hiNSCs. Surprisingly, the expression of
HMGA2 with SOX2 significantly increased reprogramming effi-
ciency toward hiNSCs, as confirmed by PAX6/NESTIN-positive
colony formation (Figure 2C). Furthermore, expressing HMGA2
with SOX2 shortened the time required for PAX6/NESTIN-
positive colonies to appear from 17 days with SOX2 alone to
7.4 days with SOX2/HMGA2 overexpression (Figure 2B).
Immunophenotyping screens have revealed that a population
of CD184+/CD271/CD44/CD24+ NSCs could be derived
from human pluripotent stem cells (Yuan et al., 2011). Therefore,
we used fluorescence-activated cell sorting to determine
whether immunophenotyping alterations were induced at an
early stage of reprogramming. Consistent with the data for theFigure 2. Role of HMGA2 in hDF-iNSC Derivation
(A) The MTT cell proliferation assay was performed in hDF control, SOX2-, SOX2
the SD of triplicate assays. **p < 0.01.
(B and C) The time of appearance (B) and efficiency of PAX6- and NESTIN-pos
SOX2/LIN28-, and SOX2/HMGA2-transduced hDFs. Error bars denote the SD o
(D) Flow cytometry analyses were performed with a negative cell surface marker o
MYC-, SOX2/LIN28-, and SOX2/HMGA2-transduced hDFs at 7 days after virus
(E) Flow cytometry analysis for the negative NSC cell surface marker, CD44, and t
(SOX2/HMGA2), and H9-NSCs.
(F) Characterization of SOX2/HMGA2-transduced hDF-iNSCs. Morphology of
nofluorescence images of hiNSCs using antibodies against PAX6, NESTIN, SOX
(G) Methylation patterns of SOX2 gene promoters were analyzed after bisulfi
SOX2/HMGA2). Filled and empty circles represent methylated and unmethylated
See also Figure S2.
Cappearance of PAX6/NESTIN-positive colonies, only SOX2/
HMGA2-overexpressing cells showed alterations in the cell pop-
ulation from CD44 positive to CD44 negative in approximately
10%of the total cells at 7 days postinfection. In addition, approx-
imately 7% of the cell population was shifted from CD184 nega-
tive to CD184 positive (Figure 2D). The majority of hiNSCs and
H9-NSCs showed CD44-negative and CD184-positive cell pop-
ulations (Figure 2E). SOX2/HMGA2-transduced hiNSCs showed
morphological features and NSC-specific marker expression
that was similar to SOX2-transduced hiNSCs or H9-NSCs
(Figure 2F). Next, we further examined NSC features
among H9-NSCs, SOX2-transduced hiNSCs, SOX2/HMGA2-
transduced hiNSCs, and SOX2/anti-let-7b-transduced hiNSCs.
H9-NSCs and hiNSCs with different combinations showed
similar expression patterns for PAX6, NESTIN, SOX2, Ki67, and
HMGA2, which was confirmed by immunostaining (Figure S2A).
At the transcriptional level, SOX2, HMGA2, PAX6, NESTIN,
MSI1, andGLASTwere induced in hiNSCs at a comparable level
as H9-NSCs (Figure S2B). Under neuronal or glial differentiation
conditions, H9-NSCs, SOX2-transduced hiNSCs, SOX2/
HMGA2-transduced hiNSCs, and SOX2/anti-let-7b-transduced
hiNSCs differentiated into neurofilament (NF)-positive neurons
or glial fibrillary acidic protein (GFAP)-positive astrocytes, and
a quantitative analysis demonstrated that the differentiation
potential of SOX2/HMGA2-transduced hiNSCs was relatively
higher for neurons and lower for astrocytes compared with
H9-NSCs or hiNSCs in other combinations (Figure S2C).
We confirmed that SOX2/HMGA2-transduced hiNSCs could
be stably maintained for more than 40 passages. The character-
istic profile of late-passage SOX2/HMGA2-transduced hiNSCs
(passage 48) was unchanged compared with early-passage
SOX2/HMGA2-transduced hiNSCs (passage 8), as judged by
NSCmarker expression, nuclear size, and nuclear abnormalities
(Figures S2D–S2F). Furthermore, NF-positive neurons or GFAP-
positive astrocytes could be generated from both early- and
late-passage SOX2/HMGA2-transduced hiNSCs, suggesting
that these cells maintain a stable differentiation capability during
continuous passaging. However, the neuronal differentiation
potential was slightly decreased in late-passage hiNSCs,
whereas the glial differentiation potential was slightly increased
(Figures S2G and S2H).
We next assessed the SOX2 DNA methylation status in hDFs,
H9-NSCs, and SOX2- and SOX2/HMGA2-transduced hiNSCs.
The methylation analysis of bisulfite-treated DNA showed that/MYC-, SOX2/LIN28-, and SOX2/HMGA2-transduced hDFs. Error bars denote
itive colony formation (C) were measured in control and SOX2-, SOX2/MYC-,
f six or nine separate assays. **p < 0.01.
f NSC, CD44, and a positive marker, CD184, in hDF control and SOX2-, SOX2/
transduction.
he positive NSC cell surface marker, CD184, in hDF-iNSCs (SOX2), hDF-iNSCs
hDF-iNSCs (SOX2/HMGA2) assessed using bright-field microscopy. Immu-
2, Ki67, and HMGA2. The scale bars represent 100 or 50 mm.
te treatment of the DNA from hDFs, H9-NSCs, and hDF-iNSCs (SOX2 and
CpGs, respectively.
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the hypomethylation of theSOX2 promoter in hiNSCswas similar
to that in H9-NSCs, suggesting that SOX2 is transcriptionally
activated (Figure 2G). These data indicate that the let-7b target
HMGA2 significantly increases the efficiency and time of
SOX2-induced reprogramming into hiNSCs, and SOX2/
HMGA2-transduced hiNSCs showed characteristics similar to
H9-NSCs in cell surface marker signatures, gene transcription
levels, and methylation patterns.
Downregulation of HMGA2 Inhibits hiNSC Proliferation
and Self-Renewal
To examine whether HMGA2 regulates hiNSC proliferation, we
transfected hiNSCs with HMGA2-targeting small interfering
RNA (siRNA) (siHMGA2) and measured cell proliferation using
BrdU labeling of dividing cells. Downregulation of HMGA2
dramatically reduced the percentage of BrdU-positive cells (Fig-
ures S1K and S1L). Furthermore, siHMGA2-transfected hiNSCs
showed a significantly reduced neurosphere size, confirmed by
the diameter of neurospheres, and decreased self-renewal,
confirmed by the number and percentage of cells generating
secondary neurospheres among primary neurosphere (Figures
S1M–S1O). Taken together, these results showed that the down-
regulation of HMGA2 with a siRNA against HMGA2 inhibits
hiNSC proliferation and self-renewal.
hiNSCs Differentiate into Neurons, Astrocytes,
and Oligodendrocytes
To examine the multipotency of hiNSCs, SOX2/HMGA2-
transduced hiNSCs were differentiated into three main neural
lineages: neurons, astrocytes, and oligodendrocytes. Subse-
quently, lineage-related markers were confirmed using immuno-
cytochemistry. After 10–15 days of neuronal induction, immature
neuronal markers; neuron-specific class III beta-tubulin (TUJ1)
and doublecortin (DCX); and neuronal intermediate filaments,
alpha-internexin (a-internexin) and NF, were detected (Fig-
ure 3A). Clonal analysis was performed to assess the self-
renewal potential of hiNSCs. Neuronal differentiation was
induced, and NF and alpha-internexin were stained in clones at
multiple passages. After 10–25 days of neuronal induction, the
mature neuronal marker, MAP2; the dopaminergic and norad-
renergic neuron marker, tyrosine hydroxylase (TH); and the
cholinergic neuron marker, choline acetyltransferase (ChAT),
were expressed at similar levels compared with H9-NSCs (Fig-
ures 3A and S3A). The astrocytic differentiation of hiNSCs
yielded GFAP-positive cells. Furthermore, cells double positive
for the oligodendrocyte markers, O4 and OLIG2, were detectedFigure 3. Functional Characterization of SOX2/HMGA2-Transduced hD
(A) Immunocytochemical analysis of hDF-iNSCs (SOX2/HMGA2) after differentiatio
and TUJ1), astrocytes (GFAP), and oligodendrocytes (OLIG2 and O4). The scal
dendrocyte generation was measured according to the NF+, GFAP+, and O4+ c
triplicate images.
(B) Representative images of sodium currents and action potential of hiNSC-der
(C) Voltage-clamp recording after blocking sodium currents using lidocaine (0.1%
(D) Voltage-clamp recording of sodium current restoration after washout.
(E) Transplantation of CM-DiI-labeled hiNSCs into the hippocampal region of 4
(GFAP), and oligodendrocytes (MBP) and colocalized with CM-DiI (arrows). Som
scale bars represent 50 mm.
See also Figure S3.
Cafter 20–35 days of induction toward oligodendroglial fate.
The various differentiation potentials of SOX2/HMGA2-
transduced hiNSCs were measured by the percentages of NF-,
GFAP-, and O4-positive cells among the total number of nuclei
(Figure 3A).
To evaluate the functionality of the hiNSCs, we examined the
electrophysiological properties. We observed that hiNSCs
generated neurons expressing sodium currents, resulting in mul-
tiple action potentials. The sodium current (or inward current)
and action potentials were inhibited using the sodium channel
blocker lidocaine and restored to normal status after washout
(Figures 3B–3D and S3B–S3D). These data revealed that hiNSCs
aremultipotent, and neurons from hiNSCs showed the functional
membrane properties and activities of normal neurons.
Moreover, to investigate whether hiNSCs could also differen-
tiate into three lineages in vivo, CM-DiI-labeled hiNSCs were
transplanted into the hippocampal region of 4-week-old mice,
followed by immunohistochemical analysis at 3 weeks after
transplantation. As expected, some of the grafted hiNSCs
differentiated into neurons (CM-Dil+TUJ1+), astrocytes (CM-
DiI+GFAP+), or oligodendrocytes (CM-DiI+MBP+) within the brain
(indicated with arrows; Figure 3E). We also observed that a few
CM-DiI fluorescent cells were negative for these lineage markers
(indicated with asterisks), implying that these cells either main-
tained theNSC status or differentiated into cells positive for other
lineage markers, such as PSA-NCAM or DCX (Figures 3E and
S3E). Taken together, these results suggest that transplanted
hiNSCs survive and differentiate into neurons, astrocytes, and
oligodendrocytes in vivo and in vitro.
HMGA2 Facilitates the Efficient Reprogramming
of Various Somatic Cells into hiNSCs
We next assessed whether human umbilical cord blood cells
(hUCB) could be used as a source for iNSC reprogramming,
as, in contrast to fibroblasts, these cells are acquired without
invasive procedures and they retain minimal genetic mutations
(Broxmeyer et al., 2011; Giorgetti et al., 2012). MSC populations
were isolated from hUCBs as previously described (Kim et al.,
2013). Following SOX2/HMGA2 transduction, hUCB-MSCs
formed networks with colonies at the intersections. hUCB-
MSC-derived iNSC colonies appeared at 7–12 days postinfec-
tion, and these cells were immunocytochemically demonstrated
to be iNSCs through positive staining for PAX6 and NESTIN (Fig-
ure 4A). It has been reported that MSCs are positive for CD73
and CD105 but negative for the hematopoietic markers CD34,
CD45, and HLA-DR (Dominici et al., 2006). hUCB-MSC-derivedF-iNSCs In Vitro and In Vivo
n into threemajor cell types: neurons (a-internexin, TH, DCX, ChAT, NF,MAP2,
e bars represent 50 or 10 mm. Quantification of neuron, astrocyte, and oligo-
ells, respectively, over the total number of cells. Error bars denote the SD of
ived neurons recorded using voltage-clamp readings.
).
-week-old mice. hiNSCs were differentiated into neurons (TUJ1), astrocytes
e hiNSCs showed CM-DiI fluorescence without colocalization (asterisks). The
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iNSCs were negative for CD73 and CD105, suggesting that the
cell surface marker signature had changed (Figure S4A). We
observed that HMGA2 expression was significantly higher
in hUCB-MSCs compared with hDFs (Figure S4B). SOX2/
HMGA2-transduced hUCB-MSCs generated 3- to 4-fold more
PAX6/NESTIN-positive colonies compared with SOX2-trans-
duced hUCB-MSCs (Figure S4C). To examine the proliferation
of H9-NSCs and hiNSC lines derived from different cell sources
and combinations of transgenes, we measured the cellular
growth rate. We observed that the cellular growth rates of
H9-NSCs and hiNSCs were not significantly different, indicating
that H9-NSCs and hiNSCs had similar proliferation capacities
(Figure S4D).
To explore whether senescent hUCB-MSCs could be induced
into neural stem cells, we transduced SOX2 alone or in com-
bination with let-7-targeting factors. To this end, senescent
hUCB-MSCs with senescence-associated-b-galactosidase ac-
tivity were transduced with SOX2, SOX2/MYC, SOX2/LIN28,
and SOX2/HMGA2 (Figure 4B). Strikingly, only SOX2/HMGA2
overexpression promoted the formation of hiNSC colonies,
whereas SOX2/MYC and SOX2/LIN28 induced morphological
changes but did not generate hiNSC colonies (Figure 4B).
SOX2/HMGA2 overexpression induced the appearance of two
to four colonies from 1 3 105 senescent hUCB-MSCs (conver-
sion efficiency of 0.004–0.008%) at 3 weeks after infection (Fig-
ure 4C). Senescent hUCB-MSC-derived iNSCs showed high
SOX2, MASH1, BLBP, and NESTIN expression, comparable to
H9-NSCs (Figure S4F).
We next attempted to generate hiNSCs from the CD34+
fraction of hUCB cells through transduction with SOX2/
HMGA2. hUCB CD34+ cells were purified using standard
immunomagnetic selection, showing 84.15% purity (Figure 4D).
For the stimulation of mitotic division, hUCB CD34+ cells were
cultured with cytokines (SCF, Flt3L, TPO, and interleukin-6) for
3 days before retrovirus infection. The cells were subsequently
plated onto feeder cells, and 10–14 days after infection, iNSC
colonies appeared (Figure 4E). hUCB CD34+ cells did not
significantly express NSC or neuron-specific markers, indi-
cating the absence of a neural precursor-like population (Fig-
ure S4E). Immunocytochemical staining and RT-PCR revealed
that hUCB CD34+ iNSCs were established, showing the posi-Figure 4. Efficient Conversion of Various Somatic Cells with HMGA2
(A) Generation of iNSCs from human-umbilical-cord-blood-derived mesenchym
after virus transduction. hUCB-MSC-derived iNSCs were immunostained wit
250 or 100 mm.
(B) Morphology of replicative senescent hUCB-MSCs transduced with SOX2, SO
hUCB-MSCs were assessed for b-galactosidase activity. Early iNSC clusters we
(C) Quantification of the amount of PAX6- and NESTIN-positive colony forma
transduced replicative senescent hUCB-MSCs. Error bars denote the SD of tripl
(D) Representative dot plot images for the purity of CD34+ cells through a flow c
mononuclear cells. FSC, forward scatter; SSC, side scatter.
(E) Schematic presentation of the strategy for reprogramming hUCB-CD34+ cell
(F) Characterization of hUCB-CD34+ iNSCs (SOX2/HMGA2) using immunocytoc
NESTIN, and SOX2 and a proliferation marker, Ki67. The scale bars represent 50
(G) Immunocytochemical analysis of hUCB-CD34+ iNSCs (SOX2/HMGA2) after d
oligodendrocytes (O4). The scale bars represent 50 mm.
(H) The efficiency of PAX6- and NESTIN-positive colony formation was meas
hUCB-CD34+ cells. Error bars denote the SD of six separate assays. **p < 0.01.
See also Figure S4.
Ctive expression of PAX6, SOX2, Ki67, HMGA2, MASH1, BLBP,
and NESTIN (Figures 4F and S4F). Furthermore, these
hUCB CD34+ iNSCs developed into neurons, astrocytes
and oligodendrocytes (Figure 4G). SOX2 alone was sufficient
to generate hUCB CD34+ iNSCs but with low efficiency.
Coexpressing SOX2 and HMGA2 in hUCB CD34+ cells
increased the frequency of PAX6/NESTIN-positive colony for-
mation 10- to 20-fold (Figure 4H). In summary, efficient direct
reprogramming through the synergistic interaction of SOX2
and HMGA2 facilitates the conversion of various somatic cells
into hiNSCs.
DISCUSSION
The results obtained in the present study provide compelling
evidence that HMGA2/let-7 plays an important role in the direct
reprogramming of hDFs, hMSCs, and hUCB CD34+ cells toward
hiNSCs and in the maintenance of hiNSC self-renewal. Impor-
tantly, the coexpression of SOX2 and HMGA2 significantly
shortened the turnaround time and enhanced reprogramming
efficiency; thus, cord blood cells or senescent cells can be re-
programmed into hiNSCs. Recent studies have shown that
cord-blood-derived CD133+ progenitor cells are converted
into neuronal-like cells (CB-iNCs) through the ectopic expression
of SOX2 and MYC (Giorgetti et al., 2012). However, CB-iNCs
showed limited neuronal differentiation, whereas in the present
study, hUCB CD34+ iNSCs showed trilineage neural differentia-
tion potential.
Senescence has been associated with physiological aging,
and it has been suggested that this process is a barrier to reprog-
ramming, reflecting a loss of replicative potential and upregula-
tion of cell-cycle-dependent kinase inhibitors (Banito and Gil,
2010). We observed that HMGA2 could overcome senes-
cence-induced barriers, potentially providing a clinical strategy
for the production of neural-disease-specific hiNSCs. Because
hiNSCs acquire a rejuvenated state and self-renewal, retained
toxic or pathogenic metabolites in patient-specific hiNSCs can
be diluted, leading to a healthy status more suitable for trans-
plantation (Liu et al., 2012). Therefore, the generation of
patient-specific hiNSCs using this protocol might represent a
powerful tool for elucidating the molecular mechanismsal stem cells with SOX2/HMGA2. Neurosphere-like colonies appeared 7 days
h PAX6 (red), NESTIN (green), and DAPI (blue). The scale bars represent
X2/MYC, SOX2/LIN28, or SOX2/HMGA2 after 21 days. Replicative senescent
re generated only through SOX2/HMGA2 transduction.
tion in control and SOX2-, SOX2/MYC-, SOX2/LIN28-, and SOX2/HMGA2-
icate assays.
ytometric analysis. The cells were 84.15% positive for CD34 after sorting from
s into hiNSCs.
hemistry. The cells were stained for the NSC-specific markers PAX6, HMGA2,
mm.
ifferentiation into three major cell types: neurons (NF); astrocytes (GFAP); and
ured in control hUCB-CD34+ cells, SOX2-, and SOX2/HMGA2-transduced
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underlying neural diseases and might have implications for
therapeutic applications.
To obtain deeper insight into the role of let-7, known targets of
let-7, MYC, LIN28, and HMGA2 were overexpressed together
with SOX2 (Mayr et al., 2007; Rybak et al., 2008; Sampson
et al., 2007). Although these factors showed a positive regulation
of colony formation, the effect of each factor on proliferation was
inconsistent with colony formation (Figure 2), suggesting that
each factor has a different mechanistic function in reprogram-
ming in addition to the increase in proliferation. This idea is sup-
ported by other reports that MYC, a well-known proliferation
stimulator (Dang, 2012), promotes the transcription of active
genes (Lin et al., 2012; Nie et al., 2012). LIN28 assists iPSC
formation, depending on the acceleration of the division rate
(Hanna et al., 2009). Nonetheless, HMGA2 showed the most-
efficient reprogramming into iNSCs, although it showed the
least-proliferative potential, suggesting that HMGA2 retains far
more mechanistic potential for iNSC reprogramming than other
factors.
HMGA2 can be a potent regulator of higher-order chromatin
compaction during reprogramming. Indeed, the compact chro-
matin structure induced through the linker histone H1 interferes
with the pluripotency of embryonic stem cells (ESCs) and effi-
ciency of iPSC reprogramming (Gaspar-Maia et al., 2009; Zhang
et al., 2012). The conversion of the chromatin structure into a
global open state through competition with the linker histone
H1 might be closely associated with the positive effect of
HMGA2 on hiNSC derivation (Catez et al., 2004; Kishi et al.,
2012). Moreover, we found that HMGA2 facilitates a high self-
renewal and neurogenic capacity in hiNSCs, consistent with
the reports that HMGA2 is a key factor for sustaining early-stage
neural stem cells during development (Kishi et al., 2012; Miller
and Gauthier, 2007).
Furthermore, in the present study, we showed that hUCB-
derived MSCs express substantially higher levels of HMGA2
than hDFs and are more prone to reprogramming into iNSCs
(Figure S4). Upregulated HMGA2 levels might reflect the higher
reprogramming efficiency of MSCs into iPSCs (Sugii et al.,
2010; Sun et al., 2009) or iNSCs compared with fibroblasts.
These reports suggest that HMGA2 is a contributor to SOX2-
mediated iNSC reprogramming through mechanistic regulation.
Thus, it will be worthwhile to determine the mechanism underly-
ing the regulatory role of HMGA2 during reprogramming in future
studies.EXPERIMENTAL PROCEDURES
Cell Derivation, Generation, and Viral Infection
hUCB-MSCs and hUCB CD34+ cells were isolated as previously described
(Kim et al., 2013). Briefly, hUCB-MSCs were obtained from the umbilical
cord blood (UCB) of 20- to 30-year-old mothers immediately after full-term
delivery; the mothers were informed of the UCB procedure. Blood samples
collected within 24 hr were used. After the UCB samples were mixed with
HetaSep solution (Stem Cell Technology) at a ratio of 5:1 (v/v), the mixture
was incubated at room temperature until the red blood cells were depleted.
The supernatant was carefully collected, and the mononuclear cells were
isolated through a Ficoll (GE Healthcare Life Sciences) density-gradient centri-
fugation at 2,500 rpm for 20 min. The cells were washed twice with PBS and
seeded onto culture dishes containing growth media. The isolation and450 Cell Reports 10, 441–452, January 20, 2015 ª2015 The Authorsresearch protocols were approved by the Boramae Hospital Institutional
Review Board (IRB) and the IRB of Seoul National University (1109/001-006).
The commercial cell line hDFs (Life Technologies) were purchased. Retro-
virus was produced as previously described (Yu et al., 2012). To generate
iNSCs, retroviral factors, SOX2, HMGA2, MYC, and LIN28 were transduced
into hDFs, hUCB-MSCs, and hUCB CD34+ cells. After expansion of the cells,
medium was changed to the NSC maintenance medium with growth factors.
NSC-like colonies were collected and transferred to neurosphere culture con-
dition. Cells were cultured as neurosphere and grown as attached cells on
PLO/FN-coated dishes, repeatedly. More detailed information can be found
in the Supplemental Experimental Procedures.
microRNA Microarray Analysis
Total RNA was extracted from the cells using Trizol reagent; 100 ng of total
RNA was labeled and hybridized using the Agilent miRNA Complete Labeling
and Hyb Kit to generate fluorescently labeled miRNAs according to the man-
ufacturer’s instructions. The labeled miRNA signals were scanned using an
Agilent microarray scanner. Raw data (GEO accession number: GSE59301)
were extracted using the software provided by Agilent Feature Extraction Soft-
ware (v11.0.1.1). The raw data for the same gene were then summarized auto-
matically in Agilent feature extraction protocol to generate Gene view file,
which provided expression data for each gene probed on the array.
Array data were filtered by gIsGeneDetected = 1 in all samples (1: detected).
Selected miRNA gtotalGeneSignal value was transformed by logarithm and
normalized by quantile method. The comparative analysis between test
sample and control sample was carried out using fold change.
All data analysis and visualization of differentially expressed genes was
conducted using R statistical language v. 2.15.0.
Quantitative Real-Time PCR
Total RNAwas extracted from cells using TRIzol reagent according to theman-
ufacturer’s instructions. cDNA was synthesized using the Superscript III First-
Strand Synthesis System (Invitrogen). Real-time PCR was performed using
SYBR Green PCR Master Mix (Applied Biosystems). ABI 7300 sequence
detection system with supplied software (Applied Biosystems) was used to
quantify gene expression. Each gene was normalized to GAPDH as a house-
keeping control, and gene expression levels were measured in at least three
independent analyses. Primers used for qRT-PCR are provided in Table S1.
In Vitro Differentiation
For neural differentiation, iNSCs were seeded at a density of 1,000 cells/well
onto poly-L-ornithine/fibronectin-coated coverslips in 24-well plates contain-
ing iNSC maintenance medium (ReNcell NSC maintenance media; Millipore).
After 24 hr, the medium was changed to Neurocult (Stem Cell Technology)
for random differentiation. After 1 week of differentiation in Neurocult, the
medium was changed for the induction of three specific lineages (neuron,
astrocyte, and oligodendrocyte). The neuronal induction medium contained
a 1:1 mixture of Neurobasal medium (GIBCO BRL) and Dulbecco’s modified
Eagle’s medium (DMEM)/F12 medium (GIBCO BRL) supplemented with B27
(GIBCO BRL), Gmax (GIBCO BRL), retinoic acid (RA) (Sigma), ascorbic acid
(Sigma), brain-derived neurotrophic factor (Peprotech), glial-cell-line-derived
neurotrophic factor (Peprotech), and forskolin (Sigma). The astrocyte induction
medium contained DMEM (high glucose) supplemented with N2 (GIBCOBRL),
Gmax, and 1% fetal bovine serum. Two types of oligodendrocyte induction
media were used as previously described (Hu et al., 2009). DMEM/F12 supple-
mented with N2, MEM nonessential amino acids solution (MEMNEAA)(GIBCO
BRL), heparin (Sigma), RA, sonic hedgehog (Peprotech), and B27 was used for
2 weeks and was subsequently changed to DMEM/F12 supplemented with
N2, B27, MEM NEAA, T3, cyclic AMP (Sigma), platelet-derived growth factor
(Peprotech), insulin-like growth factor (R&D Systems), and neurotrophin-3
(Sigma) for 2 weeks.
Patch-Clamp Reading
Whole-cell patch-clamp recordings in neurons derived from iNSCs were per-
formed using an EPC 10 USB amplifier (HEKA Electronik) at room temperature
(22C ± 1C). The recording chamber was filled with continuously flowing
Tyrode solution (flow rate: 10 ml/min). Patch electrodes were generated
from borosilicate glass capillaries using a PC-10 puller (Narishige Company).
The resistance of the electrode was 4–7 MU when filled with pipette solution.
The data were acquired and analyzed using the Pulse program version 8.67
(HEKA Electronik) and Origin 6.1 software (MicroCal). The current was filtered
at 3 kHz using a four-pole Bessels filter and digitized at 10 kHz. Tyrode solution
contained 143 mM NaCl, 5.4 mM KCl, 0.5 mMMgCl2, 1.8 mM CaCl2, 0.5 mM
NaHPO4, 10 mM glucose, and 5 mM 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES), and the pH was adjusted to 7.5 with NaOH. The pipette
solution contained 150 mM KCl, 1.0 mM MgCl2, 10 mM HEPES, 5 mM EGTA,
and 2 mM Mg-ATP, and the pH was adjusted to 7.2 with NaOH. Lidocaine
(0.1%) was used to block the Na current.
Transplantation of the hiNSCs into Mice
The hiNSCs were detached from culture dishes by using Accutase. The
hiNSCs were labeled and suspended in PBS. Balb/c mice were obtained
from Jackson Laboratory. Mice were group housed in the animal facility of
Seoul National University. All experiments were approved by and followed
the regulations of the Institute of Laboratory Animals Resources (SNU-
120821-5). Four-week-old mice were anesthetized, and labeled cells were
transplanted into hippocampal regions. After 3 weeks, mice were sacrificed
and brain was isolated. After cryosectioning, immunohistochemistry was
performed to trace the transplanted hiNSCs and differentiated hiNSCs that
integrated into mice brain. More detailed information can be found in the
Supplemental Experimental Procedures.
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